Table 10.
Median regression model of RBD (receptor-binding domain) IgG BAU/ml at 48 weeks after second dose
| Univariable |
Multivariable |
|||
|---|---|---|---|---|
| β (95% CI) | p | β (95% CI) | p | |
| Age & Dose | ||||
| 30–50 with 3 Doses | Ref. | Ref. | ||
| 70+ with 3 Doses | −133 (−554, 513) | 0.65 | 451 (214, 747) | 0.041 |
| 70+ with 4 Doses | 2726 (2195, 3250) | <0.0001 | 2674 (2415, 3116) | <0.0001 |
| Female or non-binary | −392 (−1346, 307) | 0.27 | 93.2 (−91.2, 358) | 0.57 |
| Cardiovascular Disease | 987 (212, 1510) | 0.0043 | 40.9 (−218, 271) | 0.84 |
| Cancer | 1223 (454, 1900) | 0.014 | 161 (−87.4, 572) | 0.47 |
| Diabetes | −71.8 (−1163, 811) | 0.91 | −324 (−547, −89.3) | 0.11 |
| Transplant or Immunosuppressed | −1706 (−2189, −1039) | <0.0001 | −916 (−2599, −538) | 0.097 |
| BMI (per +10) | 521 (−205, 1306) | 0.22 | 266 (67, 521) | 0.097 |
| Ever had positive COVID test | 4981 (4119, 5936) | <0.0001 | 4871 (3786, 5166) | <0.0001 |
| Any mRNA-1273 Doses | 1509 (737, 2008) | <0.0001 | 888 (582, 1163) | <0.0001 |
| White | 928 (479, 1625) | 0.0066 | n/a | |
BMI, body mass index; CI, confidence interval; n/a, not applicable; RBD, receptor-binding domain.